These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 33299887)
1. Proteomic Profiling Change and Its Implies in the Early Mycosis Fungoides (MF) Using Isobaric Tags for Relative and Absolute Quantification (iTRAQ). Zhu M; Li Y; Ding C; Wang J; Ma Y; Li Z; Zhang X; Wang P Biomed Res Int; 2020; 2020():9237381. PubMed ID: 33299887 [TBL] [Abstract][Full Text] [Related]
2. Tape stripped stratum corneum samples are suitable for diagnosis and comprehensive proteomic investigation in mycosis fungoides. Qureshi HA; Azimi A; Wells J; Fernandez-Penas P Proteomics Clin Appl; 2023 May; 17(3):e2200039. PubMed ID: 36824058 [TBL] [Abstract][Full Text] [Related]
3. CCR7 expression correlates with subcutaneous involvement in mycosis fungoides skin lesions and promotes migration of mycosis fungoides cells (MyLa) through mTOR activation. Hu SC; Lin CL; Hong CH; Yu HS; Chen GS; Lee CH J Dermatol Sci; 2014 Apr; 74(1):31-8. PubMed ID: 24411580 [TBL] [Abstract][Full Text] [Related]
4. Quantitative proteomic analysis by iTRAQ for identification of candidate biomarkers in plasma from acute respiratory distress syndrome patients. Chen X; Shan Q; Jiang L; Zhu B; Xi X Biochem Biophys Res Commun; 2013 Nov; 441(1):1-6. PubMed ID: 24041686 [TBL] [Abstract][Full Text] [Related]
5. Tissue and serum lipidome shows altered lipid composition with diagnostic potential in mycosis fungoides. Xu C; Zhou D; Luo Y; Guo S; Wang T; Liu J; Liu Y; Li Z Oncotarget; 2017 Jul; 8(29):48041-48050. PubMed ID: 28624795 [TBL] [Abstract][Full Text] [Related]
6. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers. Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969 [TBL] [Abstract][Full Text] [Related]
7. [Clinical heterogeneity of poikilodermatous mycosis fungoides: A retrospective study of 12 cases]. Rohmer E; Mitcov M; Cribier B; Lipsker D; Lenormand C Ann Dermatol Venereol; 2020; 147(6-7):418-428. PubMed ID: 32229035 [TBL] [Abstract][Full Text] [Related]
8. Mycosis fungoides in plaque stage with pronounced eosinophilic infiltration, folliculotropism, and concomitant invasive squamous cell carcinoma. Terada T Int J Clin Exp Pathol; 2013; 6(4):749-56. PubMed ID: 23573323 [TBL] [Abstract][Full Text] [Related]
9. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides. Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425 [TBL] [Abstract][Full Text] [Related]
10. Expression of CD31 in Mycosis Fungoides. Jankowska-Konsur A; Kobierzycki C; Grzegrzolka J; Piotrowska A; Gomulkiewicz A; Glatzel-Plucinska N; Olbromski M; Podhorska-Okolow M; Szepietowski JC; Dziegiel P Anticancer Res; 2016 Sep; 36(9):4575-82. PubMed ID: 27630298 [TBL] [Abstract][Full Text] [Related]
11. The different faces of mycosis fungoides: results of a single-center study. Sidiropoulou P; Nikolaou V; Marinos L; Voudouri D; Komini E; Economidi A; Rigopoulos D; Stratigos A Int J Dermatol; 2020 Mar; 59(3):314-320. PubMed ID: 31782525 [TBL] [Abstract][Full Text] [Related]
12. FoxP3-positive T cell lymphoma arising in non-HTLV1 carrier: clinicopathological analysis of 11 cases of PTCL-NOS and 2 cases of mycosis fungoides. Satou A; Asano N; Kato S; Katsuya H; Ishitsuka K; Elsayed AA; Nakamura S Histopathology; 2016 Jun; 68(7):1099-108. PubMed ID: 26426838 [TBL] [Abstract][Full Text] [Related]
13. Diagnosis of mycosis fungoides: a comparative immunohistochemical study of T-cell markers using a novel anti-CD7 antibody. Cotta AC; Cintra ML; de Souza EM; Chagas CA; Magna LA; Fleury RN; Brousset P; Vassallo J Appl Immunohistochem Mol Morphol; 2006 Sep; 14(3):291-5. PubMed ID: 16932019 [TBL] [Abstract][Full Text] [Related]
14. Gene Expression Profiling of Mycosis Fungoides in Early and Tumor Stage-A Proof-of-Concept Study Using Laser Capture/Single Cell Microdissection and NanoString Analysis. Lai J; Li J; Gniadecki R; Lai R Cells; 2021 Nov; 10(11):. PubMed ID: 34831413 [TBL] [Abstract][Full Text] [Related]
15. miR-155 is involved in tumor progression of mycosis fungoides. Moyal L; Barzilai A; Gorovitz B; Hirshberg A; Amariglio N; Jacob-Hirsch J; Maron L; Feinmesser M; Hodak E Exp Dermatol; 2013 Jun; 22(6):431-3. PubMed ID: 23711069 [TBL] [Abstract][Full Text] [Related]
16. Proteomic analysis of human frontal and temporal cortex using iTRAQ-based 2D LC-MS/MS. Xu L; Sun H; Zhang Y; Guo Z; Xiao X; Zhou X; Hu K; Sun W; Wang B; Liu W Chin Neurosurg J; 2021 May; 7(1):27. PubMed ID: 33952343 [TBL] [Abstract][Full Text] [Related]
17. Utility of CD30, Ki-67, and p53 in assisting with the diagnosis of mycosis fungoides with large cell transformation. Raghavan SS; Hong EK; Kim YH; Kim J J Cutan Pathol; 2019 Jan; 46(1):33-43. PubMed ID: 30328119 [TBL] [Abstract][Full Text] [Related]
18. CADM1 is a diagnostic marker in early-stage mycosis fungoides: Multicenter study of 58 cases. Yuki A; Shinkuma S; Hayashi R; Fujikawa H; Kato T; Homma E; Hamade Y; Onodera O; Matsuoka M; Shimizu H; Iwata H; Abe R J Am Acad Dermatol; 2018 Dec; 79(6):1039-1046. PubMed ID: 29928911 [TBL] [Abstract][Full Text] [Related]
19. Proteome and cytokine serum profiling to diagnose a mycosis fungoides. Moshkovskii SA; Sokolova EE; Brattseva EV; Karpova MA; Pyatnitskiy MA; Kubanova AA; Archakov AI Proteomics Clin Appl; 2011 Aug; 5(7-8):432-9. PubMed ID: 21751413 [TBL] [Abstract][Full Text] [Related]
20. Mycosis fungoides associated with malignant melanoma and dysplastic nevus syndrome. Pielop JA; Brownell I; Duvic M Int J Dermatol; 2003 Feb; 42(2):116-22. PubMed ID: 12708999 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]